Notícias Eulerpool PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Eulerpool-AFX

PhaseBio Pharmaceuticals Notícias de ações

PhaseBio Pharmaceuticals é observado por muitos jornalistas e investidores em todo o mundo. As notícias mais recentes de PhaseBio Pharmaceuticals nós reunimos aqui.

• 12 de fevereiro ·

  Seeking Alpha
  Week In Review: CANbridge In-Licenses Gene Therapy For Rare Disease From UMass
• 7 de novembro ·

  MarketWatch
  Bankrupt PhaseBio Identifies Chiesi as Lead Bidder for Bentracimab Assets
• 24 de outubro ·

  Business Wire
  PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code
• 12 de agosto ·

  Business Wire
  PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights